A challenge competition on InnoCentive sponsored by AstraZeneca is looking for new lab tests for toxic effects of drugs on the gastrointestinal tract. . . . → Read More: Challenge Seeks Gastrointestinal Toxicity Test Methods
|
|||||
A challenge competition on InnoCentive sponsored by AstraZeneca is looking for new lab tests for toxic effects of drugs on the gastrointestinal tract. . . . → Read More: Challenge Seeks Gastrointestinal Toxicity Test Methods Biopharmaceutical company Amgen is acquiring the rights to a technology that stops the actions of inherited genes associated with a leading type of heart disease. . . . → Read More: Gene Silencing Treatments Licensed for Heart Disease A synthetic material called hyperelastic bone is shown to produce replacement bone with a 3-D printer and in lab animals supports the growth of new bone without causing an immune response. . . . → Read More: Material Developed for 3-D Printed Bone The truth is that it’s easy to update your skills and career possibilities if you think about going back to school for your master’s degree. . . . → Read More: Six Top Tech Graduate Degrees to Help Boost Your Career The Food and Drug Administration cleared for sale a system that automatically monitors blood glucose and maintains basic insulin levels in people with type 1 diabetes. . . . → Read More: FDA Clears Artificial Pancreas System for Type 1 Diabetes A new spin-off enterprise from Harvard University is commercializing technology that enables sequencing and imaging of genetic transcriptions of cells in their original tissue. . . . → Read More: Harvard Spin-Off to Sequence, Visualize RNA in Tissue A robotic device to improve the balance of people going through rehabilitation after spinal cord injury is being developed by an engineering-medical team from Columbia University and University of Louisville. . . . → Read More: Spinal Cord Injury Rehab Device in Development Early results of a clinical trial show an individual’s own immune system cells altered to attack non-Hodgkin lymphoma can cause a partial or complete response in a large percentage of patients. . . . → Read More: Trial Shows Engineered T-Cells Can Stop Lymphoma A biotechnology company is receiving a Department of Defense grant to develop a commercial-scale manufacturing process for exosomes, tiny bubbles that deliver drugs to cells in the body. . . . → Read More: DoD Grant Funds Exosome Manufacturing Process Two new spin-off enterprises are being created to develop gut-based treatments for chronic diseases using technologies from synthetic biology company Intrexon Corporation. . . . → Read More: Spin-Off Companies to Develop Chronic Disease Therapies |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |